Publication:
Rewiring Vascular Metabolism Prevents Sudden Death due to Aortic Ruptures-Brief Report.

dc.contributor.authorOller, Jorge
dc.contributor.authorGabandé-Rodríguez, Enrique
dc.contributor.authorRoldan-Montero, Raquel
dc.contributor.authorRuiz-Rodríguez, María Jesús
dc.contributor.authorRedondo, Juan Miguel
dc.contributor.authorMartín-Ventura, José Luís
dc.contributor.authorMittelbrunn, María
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)es_ES
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderFundación La Caixaes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.date.accessioned2023-03-27T09:47:29Z
dc.date.available2023-03-27T09:47:29Z
dc.date.issued2022-04
dc.description.abstractThe goal of this study was to determine whether boosting mitochondrial respiration prevents the development of fatal aortic ruptures triggered by atherosclerosis and hypertension. Ang-II (angiotensin-II) was infused in ApoE (Apolipoprotein E)-deficient mice fed with a western diet to induce acute aortic aneurysms and lethal ruptures. We found decreased mitochondrial respiration and mitochondrial proteins in vascular smooth muscle cells from murine and human aortic aneurysms. Boosting NAD levels with nicotinamide riboside reduced the development of aortic aneurysms and sudden death by aortic ruptures. Targetable vascular metabolism is a new clinical strategy to prevent fatal aortic ruptures and sudden death in patients with aortic aneurysms.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was supported by the Fondo de Investigación Sanitaria del Instituto de Salud Carlos III (PI16/188, PI19/855), the European Regional Development Fund (ERDF), and the European Commission through H2020-EU.1.1 and European Research Council grant ERC-2016-StG 715322-EndoMitTalk. This work was partially supported by Comunidad de Madrid (S2017/ BMD-3867 RENIM-CM), co-financed by European Structural and Investment Fund. M. Mittelbrunn is supported by the Miguel Servet Program (CP 19/014, Fundación de Investigación del Hospital 12 de Octubre). J. Oller and E. Gabandé-Rodríguez are supported by Juan de la Cierva (IJC2019-040152-I and IJC2018-036850-I respectively). Support was also provided by Ministerio de Ciencia e Innovación grants (RTI2018-099246-B-I00, Comunidad de Madrid and Fondo Social Europeo funds (AORTASANA-CM; J. Miguel Redondo), J. Miguel Redondo was also funded by Fundación La Caixa (HR18-00068), The Marfan Foundation USA and the CIBER-CV of Ministerio de Ciencia e Innovación (CB16/11/00264).es_ES
dc.format.number4es_ES
dc.format.page462es_ES
dc.format.volume42es_ES
dc.identifier.citationArterioscler Thromb Vasc Biol. 2022 Apr;42(4):462-469es_ES
dc.identifier.doi10.1161/ATVBAHA.121.317346es_ES
dc.identifier.e-issn1524-4636es_ES
dc.identifier.journalArteriosclerosis, thrombosis, and vascular biologyes_ES
dc.identifier.pubmedID35196876es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15708
dc.language.isoenges_ES
dc.publisherAmerican Heart Association (AHA)es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI16/188es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/H2020-EU.1.1es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/S2017/BMD-3867 RENIM-CMes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IJC2019-040152-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IJC2018-036850-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTI2018-099246-B-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/HR18-00068es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CB16/11/00264es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CB16/PI19/855es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/ERC-2016-StG/715322es_ES
dc.relation.publisherversion10.1161/ATVBAHA.121.317346es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Regulación Génica en Remodelado Vascular e Inflamaciónes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAortic Rupturees_ES
dc.subject.meshAtherosclerosises_ES
dc.subject.meshAngiotensin IIes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshDeath, Suddenes_ES
dc.subject.meshHumanses_ES
dc.subject.meshMicees_ES
dc.subject.meshMitochondrial Proteinses_ES
dc.titleRewiring Vascular Metabolism Prevents Sudden Death due to Aortic Ruptures-Brief Report.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication888da14d-e066-4686-aeb6-3a17344312d6
relation.isAuthorOfPublication9feed430-9a0d-4597-82cd-71cec263d8fe
relation.isAuthorOfPublication.latestForDiscovery888da14d-e066-4686-aeb6-3a17344312d6

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rewiring Vascular Metabolism Arterioscler Thromb Vasc Biol 2022.pdf
Size:
1.82 MB
Format:
Adobe Portable Document Format
Description:
Artículo